Stay ahead of the regulatory curve with this targeted training on the FDA’s classification of external lower extremity nerve stimulators for Restless Legs Syndrome. Discover detailed compliance obligations, special control requirements, and the actionable steps necessary for lawful market access under the new class II designation. Learn what manufacturers, sponsors, and regulatory professionals must do to ensure safety, effectiveness, and successful 510(k) submissions—while avoiding costly enforcement actions and delays.
In this course you will learn the following:
* Understand the FDA’s classification process for neurological devices, specifically for RLS nerve stimulators.
* Identify the key requirements and special controls applicable to these devices.
* Implement the necessary steps to ensure compliance with the new classification.
* Recognize the legal and regulatory consequences of failing to comply with the final rule.
